Global Lacosamide Tablets Market Growth 2026-2032
The global Lacosamide Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ('complementary therapy') to treat focal seizures (seizures that start in one area of the brain).
United States market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Lacosamide Tablets players cover UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories, Alembic Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Lacosamide Tablets Industry Forecast? looks at past sales and reviews total world Lacosamide Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Lacosamide Tablets sales for 2026 through 2032. With Lacosamide Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide Tablets industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lacosamide Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ('complementary therapy') to treat focal seizures (seizures that start in one area of the brain).
United States market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Lacosamide Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Lacosamide Tablets players cover UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories, Alembic Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Lacosamide Tablets Industry Forecast? looks at past sales and reviews total world Lacosamide Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Lacosamide Tablets sales for 2026 through 2032. With Lacosamide Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide Tablets industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lacosamide Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 50 mg/tablet
- 100 mg/tablet
- 150 mg/tablet
- 200 mg/tablet
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- UCB
- Aesica Pharmaceuticals GmbH
- Teva
- MSN Laboratories
- Alembic Pharma
- Glenmark
- Accord Healthcare
- Mylan
- Sun PharmaApotex
- Jiangxi Qingfeng Pharmaceutical
- Beijing Sihuan Pharmaceutical
- Buchang Pharmaceutical
- What is the 10-year outlook for the global Lacosamide Tablets market?
- What factors are driving Lacosamide Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Lacosamide Tablets market opportunities vary by end market size?
- How does Lacosamide Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lacosamide Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lacosamide Tablets by Country/Region, 2021, 2025 & 2032
2.2 Lacosamide Tablets Segment by Type
2.2.1 50 mg/tablet
2.2.2 100 mg/tablet
2.2.3 150 mg/tablet
2.2.4 200 mg/tablet
2.2.5 Lacosamide Tablets Sales by Type
2.2.5.1 Global Lacosamide Tablets Sales Market Share by Type (2021-2026)
2.2.5.2 Global Lacosamide Tablets Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Lacosamide Tablets Sale Price by Type (2021-2026)
2.3 Lacosamide Tablets Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 Lacosamide Tablets Sales by Application
2.3.3.1 Global Lacosamide Tablets Sale Market Share by Application (2021-2026)
2.3.3.2 Global Lacosamide Tablets Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Lacosamide Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lacosamide Tablets Breakdown Data by Company
3.1.1 Global Lacosamide Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Lacosamide Tablets Sales Market Share by Company (2021-2026)
3.2 Global Lacosamide Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Lacosamide Tablets Revenue by Company (2021-2026)
3.2.2 Global Lacosamide Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Lacosamide Tablets Sale Price by Company
3.4 Key Manufacturers Lacosamide Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lacosamide Tablets Product Location Distribution
3.4.2 Players Lacosamide Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LACOSAMIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Lacosamide Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Lacosamide Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lacosamide Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lacosamide Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Lacosamide Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lacosamide Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lacosamide Tablets Sales Growth
4.4 APAC Lacosamide Tablets Sales Growth
4.5 Europe Lacosamide Tablets Sales Growth
4.6 Middle East & Africa Lacosamide Tablets Sales Growth
5 AMERICAS
5.1 Americas Lacosamide Tablets Sales by Country
5.1.1 Americas Lacosamide Tablets Sales by Country (2021-2026)
5.1.2 Americas Lacosamide Tablets Revenue by Country (2021-2026)
5.2 Americas Lacosamide Tablets Sales by Type (2021-2026)
5.3 Americas Lacosamide Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Tablets Sales by Region
6.1.1 APAC Lacosamide Tablets Sales by Region (2021-2026)
6.1.2 APAC Lacosamide Tablets Revenue by Region (2021-2026)
6.2 APAC Lacosamide Tablets Sales by Type (2021-2026)
6.3 APAC Lacosamide Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lacosamide Tablets by Country
7.1.1 Europe Lacosamide Tablets Sales by Country (2021-2026)
7.1.2 Europe Lacosamide Tablets Revenue by Country (2021-2026)
7.2 Europe Lacosamide Tablets Sales by Type (2021-2026)
7.3 Europe Lacosamide Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide Tablets by Country
8.1.1 Middle East & Africa Lacosamide Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lacosamide Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Lacosamide Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Lacosamide Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacosamide Tablets
10.3 Manufacturing Process Analysis of Lacosamide Tablets
10.4 Industry Chain Structure of Lacosamide Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lacosamide Tablets Distributors
11.3 Lacosamide Tablets Customer
12 WORLD FORECAST REVIEW FOR LACOSAMIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Lacosamide Tablets Market Size Forecast by Region
12.1.1 Global Lacosamide Tablets Forecast by Region (2027-2032)
12.1.2 Global Lacosamide Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lacosamide Tablets Forecast by Type (2027-2032)
12.7 Global Lacosamide Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 UCB
13.1.1 UCB Company Information
13.1.2 UCB Lacosamide Tablets Product Portfolios and Specifications
13.1.3 UCB Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 UCB Main Business Overview
13.1.5 UCB Latest Developments
13.2 Aesica Pharmaceuticals GmbH
13.2.1 Aesica Pharmaceuticals GmbH Company Information
13.2.2 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product Portfolios and Specifications
13.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aesica Pharmaceuticals GmbH Main Business Overview
13.2.5 Aesica Pharmaceuticals GmbH Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Lacosamide Tablets Product Portfolios and Specifications
13.3.3 Teva Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Lacosamide Tablets Product Portfolios and Specifications
13.4.3 MSN Laboratories Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Alembic Pharma
13.5.1 Alembic Pharma Company Information
13.5.2 Alembic Pharma Lacosamide Tablets Product Portfolios and Specifications
13.5.3 Alembic Pharma Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Alembic Pharma Main Business Overview
13.5.5 Alembic Pharma Latest Developments
13.6 Glenmark
13.6.1 Glenmark Company Information
13.6.2 Glenmark Lacosamide Tablets Product Portfolios and Specifications
13.6.3 Glenmark Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Glenmark Main Business Overview
13.6.5 Glenmark Latest Developments
13.7 Accord Healthcare
13.7.1 Accord Healthcare Company Information
13.7.2 Accord Healthcare Lacosamide Tablets Product Portfolios and Specifications
13.7.3 Accord Healthcare Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Accord Healthcare Main Business Overview
13.7.5 Accord Healthcare Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Lacosamide Tablets Product Portfolios and Specifications
13.8.3 Mylan Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Sun PharmaApotex
13.9.1 Sun PharmaApotex Company Information
13.9.2 Sun PharmaApotex Lacosamide Tablets Product Portfolios and Specifications
13.9.3 Sun PharmaApotex Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sun PharmaApotex Main Business Overview
13.9.5 Sun PharmaApotex Latest Developments
13.10 Jiangxi Qingfeng Pharmaceutical
13.10.1 Jiangxi Qingfeng Pharmaceutical Company Information
13.10.2 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangxi Qingfeng Pharmaceutical Main Business Overview
13.10.5 Jiangxi Qingfeng Pharmaceutical Latest Developments
13.11 Beijing Sihuan Pharmaceutical
13.11.1 Beijing Sihuan Pharmaceutical Company Information
13.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Sihuan Pharmaceutical Main Business Overview
13.11.5 Beijing Sihuan Pharmaceutical Latest Developments
13.12 Buchang Pharmaceutical
13.12.1 Buchang Pharmaceutical Company Information
13.12.2 Buchang Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.12.3 Buchang Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Buchang Pharmaceutical Main Business Overview
13.12.5 Buchang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Lacosamide Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Lacosamide Tablets by Country/Region, 2021, 2025 & 2032
2.2 Lacosamide Tablets Segment by Type
2.2.1 50 mg/tablet
2.2.2 100 mg/tablet
2.2.3 150 mg/tablet
2.2.4 200 mg/tablet
2.2.5 Lacosamide Tablets Sales by Type
2.2.5.1 Global Lacosamide Tablets Sales Market Share by Type (2021-2026)
2.2.5.2 Global Lacosamide Tablets Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Lacosamide Tablets Sale Price by Type (2021-2026)
2.3 Lacosamide Tablets Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 Lacosamide Tablets Sales by Application
2.3.3.1 Global Lacosamide Tablets Sale Market Share by Application (2021-2026)
2.3.3.2 Global Lacosamide Tablets Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Lacosamide Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Lacosamide Tablets Breakdown Data by Company
3.1.1 Global Lacosamide Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Lacosamide Tablets Sales Market Share by Company (2021-2026)
3.2 Global Lacosamide Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Lacosamide Tablets Revenue by Company (2021-2026)
3.2.2 Global Lacosamide Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Lacosamide Tablets Sale Price by Company
3.4 Key Manufacturers Lacosamide Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lacosamide Tablets Product Location Distribution
3.4.2 Players Lacosamide Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LACOSAMIDE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Lacosamide Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Lacosamide Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Lacosamide Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Lacosamide Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Lacosamide Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Lacosamide Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lacosamide Tablets Sales Growth
4.4 APAC Lacosamide Tablets Sales Growth
4.5 Europe Lacosamide Tablets Sales Growth
4.6 Middle East & Africa Lacosamide Tablets Sales Growth
5 AMERICAS
5.1 Americas Lacosamide Tablets Sales by Country
5.1.1 Americas Lacosamide Tablets Sales by Country (2021-2026)
5.1.2 Americas Lacosamide Tablets Revenue by Country (2021-2026)
5.2 Americas Lacosamide Tablets Sales by Type (2021-2026)
5.3 Americas Lacosamide Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Tablets Sales by Region
6.1.1 APAC Lacosamide Tablets Sales by Region (2021-2026)
6.1.2 APAC Lacosamide Tablets Revenue by Region (2021-2026)
6.2 APAC Lacosamide Tablets Sales by Type (2021-2026)
6.3 APAC Lacosamide Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lacosamide Tablets by Country
7.1.1 Europe Lacosamide Tablets Sales by Country (2021-2026)
7.1.2 Europe Lacosamide Tablets Revenue by Country (2021-2026)
7.2 Europe Lacosamide Tablets Sales by Type (2021-2026)
7.3 Europe Lacosamide Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide Tablets by Country
8.1.1 Middle East & Africa Lacosamide Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Lacosamide Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Lacosamide Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Lacosamide Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacosamide Tablets
10.3 Manufacturing Process Analysis of Lacosamide Tablets
10.4 Industry Chain Structure of Lacosamide Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lacosamide Tablets Distributors
11.3 Lacosamide Tablets Customer
12 WORLD FORECAST REVIEW FOR LACOSAMIDE TABLETS BY GEOGRAPHIC REGION
12.1 Global Lacosamide Tablets Market Size Forecast by Region
12.1.1 Global Lacosamide Tablets Forecast by Region (2027-2032)
12.1.2 Global Lacosamide Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Lacosamide Tablets Forecast by Type (2027-2032)
12.7 Global Lacosamide Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 UCB
13.1.1 UCB Company Information
13.1.2 UCB Lacosamide Tablets Product Portfolios and Specifications
13.1.3 UCB Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 UCB Main Business Overview
13.1.5 UCB Latest Developments
13.2 Aesica Pharmaceuticals GmbH
13.2.1 Aesica Pharmaceuticals GmbH Company Information
13.2.2 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product Portfolios and Specifications
13.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aesica Pharmaceuticals GmbH Main Business Overview
13.2.5 Aesica Pharmaceuticals GmbH Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Lacosamide Tablets Product Portfolios and Specifications
13.3.3 Teva Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Lacosamide Tablets Product Portfolios and Specifications
13.4.3 MSN Laboratories Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Alembic Pharma
13.5.1 Alembic Pharma Company Information
13.5.2 Alembic Pharma Lacosamide Tablets Product Portfolios and Specifications
13.5.3 Alembic Pharma Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Alembic Pharma Main Business Overview
13.5.5 Alembic Pharma Latest Developments
13.6 Glenmark
13.6.1 Glenmark Company Information
13.6.2 Glenmark Lacosamide Tablets Product Portfolios and Specifications
13.6.3 Glenmark Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Glenmark Main Business Overview
13.6.5 Glenmark Latest Developments
13.7 Accord Healthcare
13.7.1 Accord Healthcare Company Information
13.7.2 Accord Healthcare Lacosamide Tablets Product Portfolios and Specifications
13.7.3 Accord Healthcare Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Accord Healthcare Main Business Overview
13.7.5 Accord Healthcare Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Lacosamide Tablets Product Portfolios and Specifications
13.8.3 Mylan Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Sun PharmaApotex
13.9.1 Sun PharmaApotex Company Information
13.9.2 Sun PharmaApotex Lacosamide Tablets Product Portfolios and Specifications
13.9.3 Sun PharmaApotex Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sun PharmaApotex Main Business Overview
13.9.5 Sun PharmaApotex Latest Developments
13.10 Jiangxi Qingfeng Pharmaceutical
13.10.1 Jiangxi Qingfeng Pharmaceutical Company Information
13.10.2 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangxi Qingfeng Pharmaceutical Main Business Overview
13.10.5 Jiangxi Qingfeng Pharmaceutical Latest Developments
13.11 Beijing Sihuan Pharmaceutical
13.11.1 Beijing Sihuan Pharmaceutical Company Information
13.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Sihuan Pharmaceutical Main Business Overview
13.11.5 Beijing Sihuan Pharmaceutical Latest Developments
13.12 Buchang Pharmaceutical
13.12.1 Buchang Pharmaceutical Company Information
13.12.2 Buchang Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.12.3 Buchang Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Buchang Pharmaceutical Main Business Overview
13.12.5 Buchang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. LacosamideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. LacosamideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50 mg/tablet
Table 4. Major Players of 100 mg/tablet
Table 5. Major Players of 150 mg/tablet
Table 6. Major Players of 200 mg/tablet
Table 7. Global LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 8. Global LacosamideTablets Sales Market Share by Type (2021-2026)
Table 9. Global LacosamideTablets Revenue by Type (2021-2026) & ($ million)
Table 10. Global LacosamideTablets Revenue Market Share by Type (2021-2026)
Table 11. Global LacosamideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global LacosamideTablets Sale by Application (2021-2026) & (K Units)
Table 13. Global LacosamideTablets Sale Market Share by Application (2021-2026)
Table 14. Global LacosamideTablets Revenue by Application (2021-2026) & ($ million)
Table 15. Global LacosamideTablets Revenue Market Share by Application (2021-2026)
Table 16. Global LacosamideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global LacosamideTablets Sales by Company (2021-2026) & (K Units)
Table 18. Global LacosamideTablets Sales Market Share by Company (2021-2026)
Table 19. Global LacosamideTablets Revenue by Company (2021-2026) & ($ millions)
Table 20. Global LacosamideTablets Revenue Market Share by Company (2021-2026)
Table 21. Global LacosamideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers LacosamideTablets Producing Area Distribution and Sales Area
Table 23. Players LacosamideTablets Products Offered
Table 24. LacosamideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global LacosamideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global LacosamideTablets Sales Market Share Geographic Region (2021-2026)
Table 29. Global LacosamideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global LacosamideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global LacosamideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global LacosamideTablets Sales Market Share by Country/Region (2021-2026)
Table 33. Global LacosamideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global LacosamideTablets Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 36. Americas LacosamideTablets Sales Market Share by Country (2021-2026)
Table 37. Americas LacosamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 39. Americas LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 40. APAC LacosamideTablets Sales by Region (2021-2026) & (K Units)
Table 41. APAC LacosamideTablets Sales Market Share by Region (2021-2026)
Table 42. APAC LacosamideTablets Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 44. APAC LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 45. Europe LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 46. Europe LacosamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 48. Europe LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa LacosamideTablets Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of LacosamideTablets
Table 54. Key Market Challenges & Risks of LacosamideTablets
Table 55. Key Industry Trends of LacosamideTablets
Table 56. LacosamideTablets Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. LacosamideTablets Distributors List
Table 59. LacosamideTablets Customer List
Table 60. Global LacosamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global LacosamideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas LacosamideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC LacosamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC LacosamideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe LacosamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa LacosamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global LacosamideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global LacosamideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global LacosamideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global LacosamideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. UCB Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 75. UCB LacosamideTablets Product Portfolios and Specifications
Table 76. UCB LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. UCB Main Business
Table 78. UCB Latest Developments
Table 79. Aesica Pharmaceuticals GmbH Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 80. Aesica Pharmaceuticals GmbH LacosamideTablets Product Portfolios and Specifications
Table 81. Aesica Pharmaceuticals GmbH LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Aesica Pharmaceuticals GmbH Main Business
Table 83. Aesica Pharmaceuticals GmbH Latest Developments
Table 84. Teva Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva LacosamideTablets Product Portfolios and Specifications
Table 86. Teva LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. MSN Laboratories Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 90. MSN Laboratories LacosamideTablets Product Portfolios and Specifications
Table 91. MSN Laboratories LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. MSN Laboratories Main Business
Table 93. MSN Laboratories Latest Developments
Table 94. Alembic Pharma Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharma LacosamideTablets Product Portfolios and Specifications
Table 96. Alembic Pharma LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Alembic Pharma Main Business
Table 98. Alembic Pharma Latest Developments
Table 99. Glenmark Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 100. Glenmark LacosamideTablets Product Portfolios and Specifications
Table 101. Glenmark LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Glenmark Main Business
Table 103. Glenmark Latest Developments
Table 104. Accord Healthcare Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 105. Accord Healthcare LacosamideTablets Product Portfolios and Specifications
Table 106. Accord Healthcare LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Accord Healthcare Main Business
Table 108. Accord Healthcare Latest Developments
Table 109. Mylan Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan LacosamideTablets Product Portfolios and Specifications
Table 111. Mylan LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Mylan Main Business
Table 113. Mylan Latest Developments
Table 114. Sun PharmaApotex Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun PharmaApotex LacosamideTablets Product Portfolios and Specifications
Table 116. Sun PharmaApotex LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun PharmaApotex Main Business
Table 118. Sun PharmaApotex Latest Developments
Table 119. Jiangxi Qingfeng Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 120. Jiangxi Qingfeng Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 121. Jiangxi Qingfeng Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Jiangxi Qingfeng Pharmaceutical Main Business
Table 123. Jiangxi Qingfeng Pharmaceutical Latest Developments
Table 124. Beijing Sihuan Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Sihuan Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 126. Beijing Sihuan Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Beijing Sihuan Pharmaceutical Main Business
Table 128. Beijing Sihuan Pharmaceutical Latest Developments
Table 129. Buchang Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 130. Buchang Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 131. Buchang Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Buchang Pharmaceutical Main Business
Table 133. Buchang Pharmaceutical Latest Developments
Table 1. LacosamideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. LacosamideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50 mg/tablet
Table 4. Major Players of 100 mg/tablet
Table 5. Major Players of 150 mg/tablet
Table 6. Major Players of 200 mg/tablet
Table 7. Global LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 8. Global LacosamideTablets Sales Market Share by Type (2021-2026)
Table 9. Global LacosamideTablets Revenue by Type (2021-2026) & ($ million)
Table 10. Global LacosamideTablets Revenue Market Share by Type (2021-2026)
Table 11. Global LacosamideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global LacosamideTablets Sale by Application (2021-2026) & (K Units)
Table 13. Global LacosamideTablets Sale Market Share by Application (2021-2026)
Table 14. Global LacosamideTablets Revenue by Application (2021-2026) & ($ million)
Table 15. Global LacosamideTablets Revenue Market Share by Application (2021-2026)
Table 16. Global LacosamideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global LacosamideTablets Sales by Company (2021-2026) & (K Units)
Table 18. Global LacosamideTablets Sales Market Share by Company (2021-2026)
Table 19. Global LacosamideTablets Revenue by Company (2021-2026) & ($ millions)
Table 20. Global LacosamideTablets Revenue Market Share by Company (2021-2026)
Table 21. Global LacosamideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers LacosamideTablets Producing Area Distribution and Sales Area
Table 23. Players LacosamideTablets Products Offered
Table 24. LacosamideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global LacosamideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global LacosamideTablets Sales Market Share Geographic Region (2021-2026)
Table 29. Global LacosamideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global LacosamideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global LacosamideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global LacosamideTablets Sales Market Share by Country/Region (2021-2026)
Table 33. Global LacosamideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global LacosamideTablets Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 36. Americas LacosamideTablets Sales Market Share by Country (2021-2026)
Table 37. Americas LacosamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 39. Americas LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 40. APAC LacosamideTablets Sales by Region (2021-2026) & (K Units)
Table 41. APAC LacosamideTablets Sales Market Share by Region (2021-2026)
Table 42. APAC LacosamideTablets Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 44. APAC LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 45. Europe LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 46. Europe LacosamideTablets Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 48. Europe LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa LacosamideTablets Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa LacosamideTablets Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa LacosamideTablets Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa LacosamideTablets Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of LacosamideTablets
Table 54. Key Market Challenges & Risks of LacosamideTablets
Table 55. Key Industry Trends of LacosamideTablets
Table 56. LacosamideTablets Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. LacosamideTablets Distributors List
Table 59. LacosamideTablets Customer List
Table 60. Global LacosamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global LacosamideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas LacosamideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC LacosamideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC LacosamideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe LacosamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa LacosamideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa LacosamideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global LacosamideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global LacosamideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global LacosamideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global LacosamideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. UCB Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 75. UCB LacosamideTablets Product Portfolios and Specifications
Table 76. UCB LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. UCB Main Business
Table 78. UCB Latest Developments
Table 79. Aesica Pharmaceuticals GmbH Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 80. Aesica Pharmaceuticals GmbH LacosamideTablets Product Portfolios and Specifications
Table 81. Aesica Pharmaceuticals GmbH LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Aesica Pharmaceuticals GmbH Main Business
Table 83. Aesica Pharmaceuticals GmbH Latest Developments
Table 84. Teva Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva LacosamideTablets Product Portfolios and Specifications
Table 86. Teva LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. MSN Laboratories Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 90. MSN Laboratories LacosamideTablets Product Portfolios and Specifications
Table 91. MSN Laboratories LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. MSN Laboratories Main Business
Table 93. MSN Laboratories Latest Developments
Table 94. Alembic Pharma Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharma LacosamideTablets Product Portfolios and Specifications
Table 96. Alembic Pharma LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Alembic Pharma Main Business
Table 98. Alembic Pharma Latest Developments
Table 99. Glenmark Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 100. Glenmark LacosamideTablets Product Portfolios and Specifications
Table 101. Glenmark LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Glenmark Main Business
Table 103. Glenmark Latest Developments
Table 104. Accord Healthcare Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 105. Accord Healthcare LacosamideTablets Product Portfolios and Specifications
Table 106. Accord Healthcare LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Accord Healthcare Main Business
Table 108. Accord Healthcare Latest Developments
Table 109. Mylan Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan LacosamideTablets Product Portfolios and Specifications
Table 111. Mylan LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Mylan Main Business
Table 113. Mylan Latest Developments
Table 114. Sun PharmaApotex Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun PharmaApotex LacosamideTablets Product Portfolios and Specifications
Table 116. Sun PharmaApotex LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun PharmaApotex Main Business
Table 118. Sun PharmaApotex Latest Developments
Table 119. Jiangxi Qingfeng Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 120. Jiangxi Qingfeng Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 121. Jiangxi Qingfeng Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Jiangxi Qingfeng Pharmaceutical Main Business
Table 123. Jiangxi Qingfeng Pharmaceutical Latest Developments
Table 124. Beijing Sihuan Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Sihuan Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 126. Beijing Sihuan Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Beijing Sihuan Pharmaceutical Main Business
Table 128. Beijing Sihuan Pharmaceutical Latest Developments
Table 129. Buchang Pharmaceutical Basic Information, LacosamideTablets Manufacturing Base, Sales Area and Its Competitors
Table 130. Buchang Pharmaceutical LacosamideTablets Product Portfolios and Specifications
Table 131. Buchang Pharmaceutical LacosamideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Buchang Pharmaceutical Main Business
Table 133. Buchang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of LacosamideTablets
Figure 2. LacosamideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global LacosamideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global LacosamideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. LacosamideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. LacosamideTablets Sales Market Share by Country/Region (2025)
Figure 10. LacosamideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50 mg/tablet
Figure 12. Product Picture of 100 mg/tablet
Figure 13. Product Picture of 150 mg/tablet
Figure 14. Product Picture of 200 mg/tablet
Figure 15. Global LacosamideTablets Sales Market Share by Type in 2026
Figure 16. Global LacosamideTablets Revenue Market Share by Type (2021-2026)
Figure 17. LacosamideTablets Consumed in Adults
Figure 18. Global LacosamideTablets Market: Adults (2021-2026) & (K Units)
Figure 19. LacosamideTablets Consumed in Children
Figure 20. Global LacosamideTablets Market: Children (2021-2026) & (K Units)
Figure 21. Global LacosamideTablets Sale Market Share by Application (2025)
Figure 22. Global LacosamideTablets Revenue Market Share by Application in 2026
Figure 23. LacosamideTablets Sales by Company in 2026 (K Units)
Figure 24. Global LacosamideTablets Sales Market Share by Company in 2026
Figure 25. LacosamideTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global LacosamideTablets Revenue Market Share by Company in 2026
Figure 27. Global LacosamideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global LacosamideTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas LacosamideTablets Sales 2021-2026 (K Units)
Figure 30. Americas LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC LacosamideTablets Sales 2021-2026 (K Units)
Figure 32. APAC LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe LacosamideTablets Sales 2021-2026 (K Units)
Figure 34. Europe LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa LacosamideTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas LacosamideTablets Sales Market Share by Country in 2026
Figure 38. Americas LacosamideTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 41. United States LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC LacosamideTablets Sales Market Share by Region in 2026
Figure 46. APAC LacosamideTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 49. China LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe LacosamideTablets Sales Market Share by Country in 2026
Figure 57. Europe LacosamideTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa LacosamideTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of LacosamideTablets in 2026
Figure 74. Manufacturing Process Analysis of LacosamideTablets
Figure 75. Industry Chain Structure of LacosamideTablets
Figure 76. Channels of Distribution
Figure 77. Global LacosamideTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global LacosamideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global LacosamideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global LacosamideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global LacosamideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global LacosamideTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of LacosamideTablets
Figure 2. LacosamideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global LacosamideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global LacosamideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. LacosamideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. LacosamideTablets Sales Market Share by Country/Region (2025)
Figure 10. LacosamideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50 mg/tablet
Figure 12. Product Picture of 100 mg/tablet
Figure 13. Product Picture of 150 mg/tablet
Figure 14. Product Picture of 200 mg/tablet
Figure 15. Global LacosamideTablets Sales Market Share by Type in 2026
Figure 16. Global LacosamideTablets Revenue Market Share by Type (2021-2026)
Figure 17. LacosamideTablets Consumed in Adults
Figure 18. Global LacosamideTablets Market: Adults (2021-2026) & (K Units)
Figure 19. LacosamideTablets Consumed in Children
Figure 20. Global LacosamideTablets Market: Children (2021-2026) & (K Units)
Figure 21. Global LacosamideTablets Sale Market Share by Application (2025)
Figure 22. Global LacosamideTablets Revenue Market Share by Application in 2026
Figure 23. LacosamideTablets Sales by Company in 2026 (K Units)
Figure 24. Global LacosamideTablets Sales Market Share by Company in 2026
Figure 25. LacosamideTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global LacosamideTablets Revenue Market Share by Company in 2026
Figure 27. Global LacosamideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global LacosamideTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas LacosamideTablets Sales 2021-2026 (K Units)
Figure 30. Americas LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC LacosamideTablets Sales 2021-2026 (K Units)
Figure 32. APAC LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe LacosamideTablets Sales 2021-2026 (K Units)
Figure 34. Europe LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa LacosamideTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa LacosamideTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas LacosamideTablets Sales Market Share by Country in 2026
Figure 38. Americas LacosamideTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 41. United States LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC LacosamideTablets Sales Market Share by Region in 2026
Figure 46. APAC LacosamideTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 49. China LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe LacosamideTablets Sales Market Share by Country in 2026
Figure 57. Europe LacosamideTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa LacosamideTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa LacosamideTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa LacosamideTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries LacosamideTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of LacosamideTablets in 2026
Figure 74. Manufacturing Process Analysis of LacosamideTablets
Figure 75. Industry Chain Structure of LacosamideTablets
Figure 76. Channels of Distribution
Figure 77. Global LacosamideTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global LacosamideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global LacosamideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global LacosamideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global LacosamideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global LacosamideTablets Revenue Market Share Forecast by Application (2027-2032)
